Thomas Paparrigopoulos, Dimitris Karaiskos, John Liappas. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Alcoholism/complicationsAlcoholism/rehabilitationAnti-Anxiety Agents/therapeutic useAntidepressive Agents/therapeutic useAntipsychotic Agents/administration & dosageAntipsychotic Agents/therapeutic useAnxiety Disorders/complicationsAnxiety Disorders/diagnosisAnxiety Disorders/drug therapyBenzodiazepines/therapeutic useBromazepam/therapeutic useDepression/complicationsDepression/diagnosisDepression/drug therapyDibenzothiazepines/administration & dosageDibenzothiazepines/therapeutic useHospitalizationHumansLife Change EventsMaleMiddle AgedQuetiapine FumarateSelf AdministrationSubstance-Related Disorders/complicationsSubstance-Related Disorders/rehabilitation
Substances: See more » Anti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsDibenzothiazepinesBenzodiazepinesQuetiapine FumarateBromazepam
Year: 2008 PMID: 18312052
Source DB: PubMed Journal: J Clin Psychiatry ISSN: 0160-6689 Impact factor: 4.384